Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia

Preeclampsia is a disease of pregnancy involving systemic endothelial dysfunction. However, cardiovascular consequences of preeclampsia are difficult to analyze in humans. The objective of the present study is to evaluate the cardiovascular dysfunction induced by preeclampsia by examining the endoth...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2016
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23283
Acceso en línea:
https://doi.org/10.1038/srep19196
https://repository.urosario.edu.co/handle/10336/23283
Palabra clave:
Carrier protein
Protein binding
Transcriptome
Animal
Cardiomegaly
Cell line
Cluster analysis
Disease model
Endothelium cell
Female
Gene expression profiling
Gene expression regulation
Gene regulatory network
Genetics
Human
Metabolism
Mortality
Mouse
Pathology
Preeclampsia
Pregnancy
Protein analysis
Protein protein interaction
Transgenic mouse
Animals
Cardiomegaly
Carrier proteins
Cell line
Cluster analysis
Endothelial cells
Female
Gene expression profiling
Gene expression regulation
Gene regulatory networks
Humans
Mice
Pre-eclampsia
Pregnancy
Protein binding
Protein interaction mapping
Protein interaction maps
Transcriptome
human
transgenic
animal
Stox1 protein
Disease models
Mice
Rights
License
Abierto (Texto Completo)
Description
Summary:Preeclampsia is a disease of pregnancy involving systemic endothelial dysfunction. However, cardiovascular consequences of preeclampsia are difficult to analyze in humans. The objective of the present study is to evaluate the cardiovascular dysfunction induced by preeclampsia by examining the endothelium of mice suffering of severe preeclampsia induced by STOX1 overexpression. Using Next Generation Sequencing on endothelial cells of mice carrying either transgenic or control embryos, we discovered significant alterations of gene networks involved in inflammation, cell cycle, and cardiac hypertrophy. In addition, the heart of the preeclamptic mice revealed cardiac hypertrophy associated with histological anomalies. Bioinformatics comparison of the networks of modified genes in the endothelial cells of the preeclamptic mice and HUVECs exposed to plasma from preeclamptic women identified striking similarities. The cardiovascular alterations in the pregnant mice are comparable to those endured by the cardiovascular system of preeclamptic women. The STOX1 mice could help to better understand the endothelial dysfunction in the context of preeclampsia, and guide the search for efficient therapies able to protect the maternal endothelium during the disease and its aftermath.